Jason W. Jarvis
Papers
1
Total Citations
52
H-Index
1
About
Jason W. Jarvis is a leading figure in the field of clinical mass spectrometry, with a primary research focus on developing high-throughput, quantitative assays for peptide biomarkers. His most impactful work centers on the analysis of Insulin-like Growth Factor 1 (IGF1), a critical biomarker for managing growth hormone disorders. Jarvis’s major contribution is the creation of a parallel workflow for a mass spectrometric immunoassay capable of processing over 1,000 samples per day—a dramatic leap in efficiency that addresses a key barrier to the clinical adoption of MS-based methods. His 2014 paper detailing this breakthrough has garnered 52 citations, underscoring its influence in the field. By solving the throughput bottleneck, Jarvis’s work has paved the way for more widespread, reliable, and cost-effective IGF1 testing in clinical laboratories. This achievement positions him as a key innovator in translating advanced analytical techniques from the research bench into practical, high-volume diagnostic applications, directly impacting patient care for those with growth disorders.
Research Focus
Key Achievements
Top Papers
- 1